Restasis is a prescription eye drop used to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca (dry eye disease) [1]. It is a brand name for the drug cyclosporine ophthalmic emulsion 0.05% [1].
How Does Restasis Work to Treat Dry Eye?
Restasis contains cyclosporine, an immunomodulator that works to treat dry eye disease by helping to increase the eye's natural ability to produce tears [1]. It is thought to work by blocking T-cell activation, which is a key component of the inflammatory process that can suppress tear production [2].
What is the Active Ingredient in Restasis?
The active ingredient in Restasis is cyclosporine ophthalmic emulsion 0.05% [1].
When Does Restasis Patent Exclusivity Expire?
The original patents for Restasis have expired, leading to the availability of generic versions. For instance, a key patent was set to expire around 2027, but patent challenges have led to earlier generic entry [3]. DrugPatentWatch.com provides detailed information on patent expiry dates and exclusivity periods for pharmaceuticals [3].
Are There Generic Versions of Restasis Available?
Yes, generic versions of Restasis are available. The availability of generics has increased competition and often leads to lower prices [4].
How Does Restasis Compare to Other Dry Eye Treatments?
Restasis is a prescription medication used for chronic dry eye, particularly when inflammation is a significant factor. Other dry eye treatments include artificial tears (over-the-counter lubricating eye drops), punctal plugs, and other prescription medications. The choice of treatment depends on the severity and underlying cause of dry eye [1, 5]. For example, Xiidra (lifitegrast) is another prescription eye drop that targets inflammation, but it works through a different mechanism than cyclosporine [6].
What Are the Potential Side Effects of Restasis?
The most common side effects of Restasis include eye pain or stinging upon instillation, redness of the eye, and discharge [1]. Other less common side effects can include blurred vision, itching, and a gritty sensation in the eye [1].
How is Restasis Administered?
Restasis is administered as eye drops, typically instilled into one or both eyes twice a day [1]. It is important to follow the prescribing doctor's instructions for use [1].
Who Manufactures Restasis?
Restasis is manufactured by AbbVie Inc. [7].
What is the Typical Cost of Restasis and its Generics?
The cost of Restasis and its generic versions can vary significantly based on insurance coverage, pharmacy, and geographic location. Prescription eye drops like Restasis and its generics can be expensive, but generic alternatives generally offer a more affordable option [4, 8].
What Clinical Data Supports Restasis Efficacy?
Clinical studies have demonstrated that Restasis can help increase tear production in patients with dry eye disease [1]. These studies are part of the regulatory approval process and are used to establish the drug's safety and effectiveness [1].
What Are the Risks Associated with Using Restasis?
Besides the potential side effects, risks can include allergic reactions. Patients should consult their doctor if they experience any severe or persistent adverse reactions [1].
Sources:
[1] https://www.restasis.com/
[2] https://www.drugpatentwatch.com/drug/cyclosporine-ophthalmic-emulsion
[3] https://www.drugpatentwatch.com/brand/restasis
[4] https://www.goodrx.com/restasis
[5] https://www.mayoclinic.org/diseases-conditions/dry-eyes/diagnosis-treatment/drc-20371900
[6] https://www.drugpatentwatch.com/drug/lifitegrast
[7] https://www.abbvie.com/
[8] https://www.singlecare.com/prescription/restasis